Emergent Biosolutions Inc. · NYSE:EBS
Emergent Biosolutions — Shareholder Meeting (May 2021)
8 slides from Emergent Biosolutions's shareholder meeting presentation, May 25, 2021
Slide 1: 2021 Annual Meeting of Stockholders
Emergent BioSolutions Inc. 2021 Annual Meeting of Stockholders 1 May 20, 2021
Slide 2: Agenda
Agenda 2 2021 Virtual Annual Meeting of Stockholders 1. Call to Order; Rules and Procedure 2. Introductions 3. Procedural Matters; Declaration of Quorum 4. Presentation of the proposals to be considered and voted on by the stockholders as set forth in the proxy statement: • Proposal No. 1: Election
Slide 3: State of the Company
State of the Company Robert G. Kramer President and Chief Executive Officer 3 2021 Virtual Annual Meeting of Stockholders
Slide 4: Key Takeaways
Key Takeaways 4 2021 Virtual Annual Meeting of StockholdersSTATE OF THE COMPANY • The state of the company today is strong and resilient – just as it has always been. • Anticipate continued need for core medical countermeasures that support preparedness and response. • The CDMO services we provide r
Slide 5: Question & Answer Session
Question & Answer Session 5 2021 Virtual Annual Meeting of Stockholders
Slide 6: Safe Harbor Statement
Safe Harbor Statement 6 2021 Virtual Annual Meeting of StockholdersINTRODUCTION This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including, without limitation, d
Slide 7: Trademarks
Trademarks 7 2021 Virtual Annual Meeting of StockholdersINTRODUCTION TRADEMARKS BioThrax® (Anthrax Vaccine Adsorbed), RSDL® (Reactive Skin Decontamination Lotion Kit), BAT® (Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine)), Anthrasil® (Anthrax Immune Globulin Intravenous (Human)), VIGIV (Vac
Slide 8: 2021 Annual Meeting of Stockholders
Emergent BioSolutions Inc. 2021 Annual Meeting of Stockholders 8 May 20, 2021
Emergent BioSolutions — Shareholder Meeting (May 2021) on 6ix